• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Cardano Price: Can the Cryptocurrency Achieve New Peaks?

user avatar

by Giorgi Kostiuk

a year ago


The Cardano price has shown significant momentum, increasing by more than 13% since the start of trading. Despite market participant uncertainty, substantial investments from 'whales' and rising large transaction volumes indicate confidence in the cryptocurrency's future.

Current Market Dynamics of Cardano

Against the backdrop of overall positive market sentiment, the Cardano price increased by over 13%. Technical indicators suggest uncertainty in the next step, as the active address count surged from 23.69K to 88.2K within a week but subsequently dropped.

Whale Activity and Large Transactions

Since the beginning of Q4, 2024, large investors holding over $10 million in ADA continued to accumulate assets. The volume of large Cardano transactions increased by nearly 300% in the past two weeks, reaching $22.6 billion.

Technical Analysis and Outlook

According to the weekly chart of ADA, the price exited the 'bearish' trend. However, following the 'bullish' crossover, a 'bearish' divergence is noticed, indicating potential weakness among the 'bulls'. Breaching the resistance zone between $0.766 and $0.87 can signal further growth, potentially exceeding $1.

In conclusion, the positive dynamics of Cardano may continue if the current positions in the resistance zone are maintained. Further growth will depend on market conditions and investor activity.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Converge Bio's AI Platform Aims to Transform Drug Development

chest

Converge Bio is leveraging its newly acquired $25 million funding to enhance its AI platform, which focuses on drastically reducing the time and costs associated with drug development.

user avatarKenji Takahashi

Converge Bio Secures $25 Million Series A Funding to Transform Drug Discovery

chest

Converge Bio, a startup based in Boston and Tel Aviv, has raised $25 million in Series A funding to enhance AI-driven drug discovery.

user avatarMaria Fernandez

Buterin Continues Charity Donations from Token Sales

chest

Vitalik Buterin continues his practice of selling unsolicited tokens and donating the proceeds to charity, emphasizing ethical considerations in cryptocurrency promotions.

user avatarRajesh Kumar

Vitalik Buterin Sells Unsolicited Tokens for 94 ETH

chest

Ethereum cofounder Vitalik Buterin has sold unsolicited tokens from his wallet, converting them into 94 ETH.

user avatarGustavo Mendoza

Grayscale Segments Crypto Market into Five Vertical Categories

chest

Grayscale has categorized its altcoin candidates into five verticals, reflecting a structured approach to the crypto market.

user avatarMiguel Rodriguez

Decline in FLOW Price Amid Controversial Asset Recovery

chest

The price of FLOW has seen a significant decline following the Flow project's controversial asset recovery actions.

user avatarLuis Flores

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.